When a group of FDA advisors recently assessed a heart device made by Abbott, the agency didn’t disclose that most of them had received payments from the company.
Related Posts
Growing demand for stronger marijuana highlights the risk of cannabis-induced psychiatric disorders
As more states legalize recreational cannabis prod
